Activating (P253R, C278F) and Dominant Negative Mutations of FGFR2: Differential Effects on Calvarial Bone Cell Proliferation, Differentiation, and Mineralization

Connective Tissue Research

Volumn 44, Issue 1, 2003, Pages 292-297

  Ratisoontorn, Chootima ^a   Fan, Gao Feng ^a   Mcentee, Kerry ^a   Nah, Hyun Duck ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Differentiation; Fgfr2; Mutations; Osteoblasts; Proliferation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; LIGAND; RECEPTOR ACTIVITY MODIFYING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENUATION; AVIAN SARCOMA VIRUS; BONE CELL; BONE DEVELOPMENT; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CHICKEN; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; MITOGENESIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CLONING, MOLECULAR; GENES, DOMINANT; MUTATION; OSTEOBLASTS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SKULL; TRANSFECTION;

ANIMALIA; AVES; AVIAN SARCOMA VIRUS; GALLUS GALLUS;

EID: 0037238162     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200390181799     Document Type: Article

References (20)

1. Fantl, W.J., Johnson, D.E., and Williams, L.T. (1993). Signalling by re- ceptor tyrosine kinases. Ann. Rev. Biochem. 62: 453 – 481.
2. Johnson, D.E., and Williams, L.T. (1993). Structural and functional diver- sity in the FGF receptor multigene family. Adv. Cancer Res. 60: 1 – 41.
3. Rice, D.P., Aberg, T., Chan, Y., Tang, Z., Kettunen, P.J., Pakarinen, L., Maxson, R.E., and Thesleff, I. (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127: 1845 – 1855.
4. De Moerlooze, L., and Dickson, C. (1997). Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr. Opin. Genet. Dev. 7: 378 – 385.
5. Muenke, M., and Schell, U. (1995). Fibroblast-growth-factor receptor mu- tations in human skeletal disorders. Trends Genet. 11: 308 – 313.
6. Celli, G., LaRochelle, W.J., Mackem, S., Sharp, R., and Merlino, G. (1998). Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J. 17: 1642 – 1655.
7. Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., and Lonai, P. (1998). Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA 95: 5082 – 5087.
8. Arman, E., Haffner-Krausz, R., Gorivodsky, M., and Lonai, P. (1999). Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc. Natl. Acad. Sci. USA 96: 11895 – 11899.
9. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., and Sutrave, P. (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper- independent retroviral vectors. J. Virol. 61: 3004 – 3012.
10. Fekete, D.M., and Cepko, C.L. (1993). Replication-competent retrovi- ral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo. Mol. Cell Biol. 13: 2604 – 2613.
11. Asahina, I., Sampath, T.K., Nishimura, I., and Hauschka, P.V. (1993). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol. 123: 921 – 933.
12. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D.B. (1997). Biological roles of fibroblast growth factor-2. Endocr. Rev. 18: 26 – 45.
13. Boudreaux, J.M., and Towler, D.A. (1996). Synergistic induction of os- teocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteo- calcin promoter. J. Biol. Chem. 271: 7508 – 7515.
14. Anderson, J., Burns, H.D., Enriquez-Harris, P., Wilkie, A.M., and Heath, J.K. (1998). Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Genet. 7: 1475 – 1483.
15. Siegel, P.M., and Muller, W.J. (1996). Mutations affecting conserved cys- teine residues within the extracellular domain of Neu promote recep- tor dimerization and activation. Proc. Natl. Acad. Sci. USA 93: 8878 – 8883.
16. Neilson, K.M., and Friesel, R.E. (1995). Constitutive activation of fibrob- last growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270: 26037 – 26040.
17. Yu, K., Herr, A.B., Waksman, G., and Ornitz, D.M. (2000). Loss of fibrob- last growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc. Natl. Acad. Sci. USA 97: 14536 – 14541.
18. Fragala, A., Tartaglia, M., Bernardini, S., Di Stasi, A.M.M., Di Rocco, C., Velardi, F., Teti, A., Battaglia, P.A., and Migliaccio, S. (1999). Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am. J. Pathol. 154: 1465 – 1477.
19. Lomri, A., Lemonnier, J., Hott, A., de Parseval, N., Lajeunie, E., Munnich, A., Renier, D., and Marie, P.J. (1998). Increased calvarial cell differ- entiation and bone matrix formation induced by fibroblast growth fac- tor receptor 2 mutations in Apert syndrome. J. Clin. Invest. 101: 1310 – 1317.
20. Mansukhani, A., Bellosta, P., Sahni, M., and Basilico, C. (2000). Sig- naling by fibroblast growth factors and fibroblast growth factor receptor 2 (FGFR2)-activating mutations block mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149: 1297 – 1308.